Dr. Ike Ahmed

MD FRCSC

Prof. Amar Agarwal

M.S., FRCS, F.R.C.Ophth

Prof. Norbert Pfeiffer

Medical Director, Mainz University Medical Center

Dr. Ronald Fellman

Dr. Davinder Grover

MD MPH

Prof. Thomas Samuelson

Dr. Richard A Lewis

Prof. Xing-Huai Sun, MD  

Prof.

Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, Simple & Fast Glaucoma treatment which effectively lowers the IOP without the need for invasive surgery.

News & Publications

Outstanding Clinical Performance

MIMS® is a rapid & minimal invasive procedure at the forefront of Interventional Glaucoma treatments. Fewer post-op complications allows for effective IOP management.

A Minimal invasive & Stent-less Treatment Glaucoma Innovation

Minimally Invasive Micro Sclerostomy is fast, accessible & effective. It works by inserting a specially designed cutting tool into the sclera & removing a small channel of tissue. This channel will remain open & contentiously drain, effectively reducing IOP.

How MIMS® Works

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use & learn, intuitive to operate & requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters & a foot pedal initiates the precise handheld cutting tool movement. 

A Ready-to-Use Surgical System

Novel Glaucoma treatment practiced globally. Learn more about Sanoculis and MIMS® surgical device innovation.

Precision Glaucoma Treatment Technology

MIMS® Testimonials

Nir Israeli

Vadim Shmukler

COO&CTO

Dr. Yossi Glovinsky

Elad Shalev

VP Marketing & Sales

Erna Kidron

Global Product & Surgical Specialist

Maayan Noach-Shaharabani

QA, RA and Product Manager

Khan Lau OD, FAAO

VP Clinical Affairs US

Yerenavs

Viselle Augenzentrum

Barzilai Medical Center

Hadasa

Samaon Assuta

Hillel Yaffe Medical Institute

Medizin University

Medica

Swiss Visio - Montchoisi

Sanoculis LTD. develops the MIMS® solution for Glaucoma surgery treatment. Our vision is to become the gold standard for effective glaucoma surgery.

Our Vision

Home

Our Vision

Interventional Glaucoma

Clinical Trial Data

Distributors Login

Contact

Contact

Menu

Our Vision

Sanoculis Leadership Team

Sanoculis Medical Advisory Board

Medical Institutional Partners

Learn

Resources

Company